Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines in Preventing Postinfluenza Deaths

J Infect Dis. 2018 Jun 20;218(2):336-337. doi: 10.1093/infdis/jix645.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aged
  • Humans
  • Influenza Vaccines*
  • Influenza, Human*
  • Medicare
  • United States
  • Vaccines, Inactivated

Substances

  • Influenza Vaccines
  • Vaccines, Inactivated